The economic burden of rotavirus infection in South Korea from 2009 to 2012.

Rotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis. Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased. However, little is known on the economic burden of rotavirus infection and it...

Full description

Bibliographic Details
Main Authors: Kyung Suk Lee, Ye-Rin Lee, So-Youn Park, In-Hwan Oh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5858784?pdf=render
id doaj-8d623d142d124587a304726a9ac1e57a
record_format Article
spelling doaj-8d623d142d124587a304726a9ac1e57a2020-11-25T01:53:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019412010.1371/journal.pone.0194120The economic burden of rotavirus infection in South Korea from 2009 to 2012.Kyung Suk LeeYe-Rin LeeSo-Youn ParkIn-Hwan OhRotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis. Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased. However, little is known on the economic burden of rotavirus infection and its variations in Korea. Here, we estimated the economic costs of rotavirus infection from 2009 to 2012 using nationwide data from the National Health Insurance Service (NHIS) claims. Socioeconomic costs were subdivided into direct and indirect and measured with a prevalence-based approach. Costs were converted from Won to United States dollars (US$). The number of children <5 years old infected with rotavirus decreased from 21,437 to 10,295 during the study period, representing a decrease in prevalence from 947 to 443 per 100,000. The sum of direct and indirect costs also decreased, from $17.3 million to $9.6 million, and the days of admission decreased from 76,000 to 38,000. However, per capita expenditures slightly increased, from $809 to $934. Thus, the economic burden of rotavirus infection decreased after implementation of rotavirus vaccination. Including the vaccine as part of the national essential vaccination program could reduce the prevalence of and economic loss from rotavirus infection in Korea.http://europepmc.org/articles/PMC5858784?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kyung Suk Lee
Ye-Rin Lee
So-Youn Park
In-Hwan Oh
spellingShingle Kyung Suk Lee
Ye-Rin Lee
So-Youn Park
In-Hwan Oh
The economic burden of rotavirus infection in South Korea from 2009 to 2012.
PLoS ONE
author_facet Kyung Suk Lee
Ye-Rin Lee
So-Youn Park
In-Hwan Oh
author_sort Kyung Suk Lee
title The economic burden of rotavirus infection in South Korea from 2009 to 2012.
title_short The economic burden of rotavirus infection in South Korea from 2009 to 2012.
title_full The economic burden of rotavirus infection in South Korea from 2009 to 2012.
title_fullStr The economic burden of rotavirus infection in South Korea from 2009 to 2012.
title_full_unstemmed The economic burden of rotavirus infection in South Korea from 2009 to 2012.
title_sort economic burden of rotavirus infection in south korea from 2009 to 2012.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description Rotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis. Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased. However, little is known on the economic burden of rotavirus infection and its variations in Korea. Here, we estimated the economic costs of rotavirus infection from 2009 to 2012 using nationwide data from the National Health Insurance Service (NHIS) claims. Socioeconomic costs were subdivided into direct and indirect and measured with a prevalence-based approach. Costs were converted from Won to United States dollars (US$). The number of children <5 years old infected with rotavirus decreased from 21,437 to 10,295 during the study period, representing a decrease in prevalence from 947 to 443 per 100,000. The sum of direct and indirect costs also decreased, from $17.3 million to $9.6 million, and the days of admission decreased from 76,000 to 38,000. However, per capita expenditures slightly increased, from $809 to $934. Thus, the economic burden of rotavirus infection decreased after implementation of rotavirus vaccination. Including the vaccine as part of the national essential vaccination program could reduce the prevalence of and economic loss from rotavirus infection in Korea.
url http://europepmc.org/articles/PMC5858784?pdf=render
work_keys_str_mv AT kyungsuklee theeconomicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT yerinlee theeconomicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT soyounpark theeconomicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT inhwanoh theeconomicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT kyungsuklee economicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT yerinlee economicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT soyounpark economicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
AT inhwanoh economicburdenofrotavirusinfectioninsouthkoreafrom2009to2012
_version_ 1724989527885348864